Transcript Penninckx_PompidouGroup

The Pompidou Group:
Its role, structure and
activities
Patrick Penninckx
Executive Secretary
[email protected] – www.coe.int/Pompidou
P2P event on"the use of drugs and its impact on public health“ – Brussels, 16 – 18 May 2011
The European Framework
Council of Europe
DG III – Social Cohesion
Pompidou Group
Set up in 1971
Incorporated into CoE in 1980
European Union
European Commission
DG - Justice, Freedom and
security
• Ministerial conference (4 years)
• Four-Year Work Programme
• EU Drugs Strategy 2005-2012
Recent Meetings:
• Action Plan 2005-2008
• Action Plan 2009-2012
15th Ministerial Conference:
3-4 November, 2010
68th Meeting of the Permanent
Correspondents:
30-31 March, 2011
EMCDDA
Set up in 1993
Based in Lisbon
Role = provide the EU
and its Member States
with an overview of
European drug problems
MoU between
Pompidou Group and
EMCDDA, November
2010
1
The Pompidou Group
(Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs)
• is an intergovernmental body formed in 1971 at the suggestion of the
French President Georges Pompidou.
• Began as an informal co-operation forum of 7 European countries
(France, Belgium, Germany, Italy, Luxembourg, Netherlands, United Kingdom) looking
to share their experience with combating drug abuse and drug
trafficking.
• Incorporated into the Council of Europe in 1980.
• Co-operation was subsequently extended to include many new
countries; at present, the Pompidou Group comprises 35 member
states.
2
The Role of the Pompidou Group
• core mission: contribute to the development of multidisciplinary, innovative,
effective and “evidence-based” drug policies in 35 member states.
• seeks to link policy, practice and science.
• provides a multidisciplinary forum at the wider European level where it is
possible for policy-makers, professionals and researchers to discuss and
exchange information and ideas on the whole range of drug misuse and
trafficking problems.
• plays a bridging role between EU countries and non-EU countries (Life skills
programme in Ukraine) as well as countries from the Mediterranean Region
(MedNet.)
• cooperates with other Council of Europe initiatives, placing special emphasis
on ethical issues and respect of human rights.
3
The Pompidou Group’s Structure
• Secretariat based in Strasbourg
• Ministerial Conference (held every 4 years) -> adopts work programme
• Permanent Correspondents = representatives of the 35 member states;
senior officials in ministries in charge of drug issues (held biannually)
• Currently, the Pompidou Group carries out activities in the following
areas:
• Prevention
• MedNET
• Treatment
• EXASS Net
• Drug Supply Reduction
• Cooperation and Assistance
Activities
• Research
• Ethics & Professional Standards
4
Prevention
Aim: Look for innovative and evidence-based practices, define quality
standards, and evaluate programs for long-term effectiveness.
•
•
•
•
Life-skills training (teens building resilience to negative influences)
Prevention of Drug Use in the Workplace
Prevention of Drug Use in Recreational Settings
Consultative Youth Forum on Drugs Prevention
•
2004-Polydrug use, 2006-families and youth, (2012- risky youth behaviour)
• Drug Prevention Support Network
• Conference on drug policy evaluation tools, Prague, May 2010
• The European Drug Prevention Prize (every two years)
5
The European
Drug Prevention Prize
•
•
•
•
Created in 2004 to recognise the importance of active
youth participation in the development of drug
prevention projects.
Awarded every 2 years -> 2004-2012
3 drug prevention projects led by youth for youth are
rewarded for their work.
Monetary benefit: 5000 €, trophy and diploma
Prize 2004
Prize 2006
Prize 2008
Prize 2010
44 applications
18 countries
31 applications
18 countries
34 applications
15 countries
80 applications
26 countries
Slovenia
Switzerland
United Kingdom
Ireland
Norway
Bulgaria
Greece
Netherlands
Spain
United Kingdom
Belgium
11 shortlisted projects
6
Treatment
Aim: Improve treatment for specific groups by adapting to new trends and
assessing the results of different approaches to treatment.
•
Provided an overview of the treatment systems in 28 countries
• Treatment Systems Overview in South-Eastern Europe (March, 2011)
• Treatment Systems Overview in Europe (October, 2010)
• Adopted a series of recommendations and orientations to improve
practices in the treatment of young (up to 25 years) drug users.
• Conferences:
– May 2010 Conference on Stimulant Use
– May 2009 Guideline development conference focused on bridging the gap
between clinical practice and evidence-based practice
7
Research
•
Aim: Assessing the impact of research on policy and supporting the use of research
evidence in policy and practice.
From 2011-2014, research will now address the following questions:
–
–
“what are the best structures to reach coherent drug policies? ”
“what models could be used to test a coherent policy’s effectiveness?”
•
•
Ad Hoc expert group on road traffic safety and substitution treatment (2011-2012)
ESSD Summer School- Intensive Course on Qualitative Drug Research for young researchers
Previous Activities include:
•
•
•
•
•
Creation of the Register on Drug Research in 2007
Signaling the latest issues that arise from drug research and promoting interaction
between research disciplines (publications)
Developing coherent drug policies
Co-operation with ESPAD and ESSD
Organized MedSPAD surveys in Lebanon, Morocco, Jordan and Egypt.
8
Ethical issues
and professional standards
Aim: Undertake reflections and devise opinions on ethical and professional issues
in the following drug and drug abuse-related areas:
•
Drug Testing
– Weighed in on drug screening at school, in the workplace, and on recruitment, the role
of insurance companies in the practice of drug testing,
– Published the whole report of findings in September 2008, along with a survey of the
situation in European schools and legislatures.
• “Vaccines" against drugs
– Conclusion: As to preventive treatment, it should not be considered under any
circumstances, and if “vaccines” were put on the market, very strict application
frameworks would have to be set up to avert the risk of misuses.
Also:
• Publication on drug addiction in the “Ethical Eye”: “Drug Addiction” (2005)
• Organized a round table in 2008 on the theme: “Research and its implications for methods of
dealing with drug addiction: the ethical challenges”
9
Drug Supply Reduction
Criminal Issues:
Aim: Co-operation among specialised services (justice, health and care services, social
services) to find alternative measures to imprisonment
• Explore links between crime and drug-use (recidivism)
• Drug Treatment in Moldovan Prisons
• Working group on the elaboration of guidelines aimed at reducing drug supply on a world-wide
scale
• Objective: developing political guidelines that will strengthen international cooperation, with the end
goal of a harmonised international control strategy
Airports: (comprises customs and law enforcement officers from 35 countries)
Aim: Harmonise tools and systems to improve drug detection in European airports, and
enhance subject-related inter-airport cooperation.
•
•
•
•
Annual reviews of the development of drug seizures at airports
Development of an Airport Crime Risk Register
Promote the undertaking of multilateral drug seizure operational activities
Regular updates of contacts, crime figures, and the Passenger Control Handbook
10
Drug Supply Reduction
Precursors:
Aim: The prevention of licit and illicit drug precursors’ diversion towards the
manufacture of illegal psychoactive substances.
Conferences:
–
–
–
13-14 October, 2011: planned conference on new threats arising in the field of precursor
diversion. (Closing the gaps in the judicial chain from the identification of suspect
assignments and backtracking to prosecution and sanction).
30 September - 1 October 2010: Conference on the prevention of drug precursors' diversion
- perspectives for national and international cooperation.
March 2009: backtracking investigation, evidence collection, sanction and prevention of drug
precursors diversion”. The target audience of the conference included magistrates,
prosecutors and judges, but also representatives from the chemical industry and law
enforcement.
11
MedNET
• Set up in 2006
• Aim: To improve the quality of drug policy implementation
in all participating countries, with greater awareness of the
cultural factors influencing intervention policies.
• 13 Member countries =Algeria, Cyprus, Egypt, France,
Greece, Italy, Jordan, Lebanon, Malta, Morocco, Portugal,
Spain, Tunisia
• Target groups: : Policy-makers, medical doctors, social workers, NGO representatives,
public associations, researchers, and administrative managers.
• Geared towards promoting interaction between professionals working on the ground
on the political, practical and scientific aspects of drug policy implementation.
• Added Value of the Network: MedSPAD- adaptation of European survey methodology
and tools to the southern Mediterranean cultural context.
12
EXASS NET
• Set up in 2007 as a European network between
stakeholders at the frontline level. It has since met 6 times,
and works at the urban, regional and national levels
• Aim: Connecting European professionals and PCs that
can provide insights into policy implementation on
topics that are of immediate concern to governments.
• Addresses topics specific to Permanent Correspondent
member cities. Upcoming meetings include:
• Berlin, May, 2011- Legal and Illegal Immigrants
• October, 2011- How Services Deal with Poly-Drug Use
• Member countries: Germany, Croatia, Russian Federation, Finland, Hungary, Moldova, Norway,
Netherland, Poland, Portugal, Romania, Slovenia, Ukraine, United-Kingdom
• Member cities: Amsterdam, Budapest, Cracow, Frankfurt, Koper, Oslo, Preston, Turku, Viseu, Zagreb,
Zaporozhye
13
Cooperation Activities
Cooperation with non-member states
Aim: Provide or exchange technical assistance for the development of drug and drug
abuse related policies in non-member states, paid for through voluntary contributions.
Mediterranean: MedNET
•Algeria, Tunisia, Morocco, Lebanon, Egypt, Jordan• Voluntary contributions from member countries for MedNET programs.
•In 2010, this program received 255 000,00 €.
•In 2011, it will receive 415 187,00 €.
•Capacity building and two-way information exchange through awareness campaigns, national
surveys, training seminars, and study visits.
Eastern and South Eastern Europe:
•Ukraine-Capacity Building, Lifeskills Training
•Moldova- Drug Harm Reduction and Treatment in Prisons
•Armenia-Reform of the Justice sector through trainings
• Romania-Drug Harm Reduction and Treatment in Prisons
•Moldova and Transnistria- Rapid Assessment of Drugs Use in Prisons
14
Cooperation Activities
Cooperation with other institutions:
•Aim: Actively seeks cooperation with other European and International
Organisations to avoid overlaps and to increase synergies.
•European Union- In-depth study of the possibilities for the co-financing of activities
in the Mediterranean Region between the European Commission and the Council of
Europe.
•EMCDDA-signed a Memorandum of Understanding, which will be elaborated in 2011
•WHO-HIPP- Joined Steering Group on Health in Prisons Programme to contribute to
the drugs in prisons program
•UNODC Regional Offices- namely in the North African and Middle East regions.
Participation in the commission on narcotic drugs (CND).
•INCB- Cooperation on backtracking precursor diversion.
15
Cooperation Activities
Cooperation activities with the civil society sector:
Activities of the Pompidou Group with the following organizations:
•ESPAD & MEDSPAD- conduct surveys and collect data on drug use in schools.
•ESSD-co-created summer schools, as well as a book on developments in social drug research
•European Playwork Association-facilitates the European Drug Prevention Prizes
•Mentor Foundation-Collaborates on school-based prevention projects.
•Skoun Addictions Centre- “Filling the Gap” project
•MENAHRA-cooperation on harm reduction through MedNET
•NGO “Innovative Projects in Prisons- cooperation on harm reduction in Moldovan
prisons
•Syracuse University- collaboration on Trans-Atlantic Executive Training
16
For further information, please visit our website
http://www.coe.int/t/dg3/pompidou/default_en.asp
Or contact our Secretariat directly
Pompidou Group
Council of Europe
F - 67075 Strasbourg - CEDEX
[email protected]
17
Thank you for your attention!
[email protected] – www.coe.int/Pompidou
18